|
162 |
|
2021 |
Clinical Practice Survey of Cryoprecipitate Utilization |
Active |
|
|
|
161 |
|
2021 |
D Alloimmunization bY Trauma? Or Not at All (DAYTONA) |
Completed |
147, 154 |
|
|
160 |
|
2021 |
Assessing the current Demand of ImmunoGlobulins, the "DIG" study |
Active |
|
|
|
159 |
|
2021 |
Is serologic reactivity of unidentified specificity (SRUS) associated with hemolytic disease of the fetus and newborn (HDFN)? |
Completed |
159 |
|
|
158 |
|
2021 |
Comparison of cryoprecipitate production & QC methods |
Active |
|
|
|
157 |
|
2021 |
We keep getting aggregates in platelets: Let’s GET AGGRIP on aggregates! |
Active |
|
|
|
156 |
|
2021 |
Incentives for blood (product) donation |
Active, Manuscript in Preparation |
|
|
|
155 |
|
2020 |
Donor demographics and COVID-19 |
Active |
|
|
|
154 |
|
2020 |
Significance of reporting ABO serology post ABOi HSCT engraftment |
Active |
|
|
|
153 |
|
2020 |
Training and Roles Assessment of Cellular Therapists (TRACT) |
Active |
|
|